as the predominant disease and again there appeared to be four main groups. The family mentioned in the introduction above is a good illustrative example. Familial chronic mucocutaneous candidiasis: This is the most important group in my present study . Twenty-two patients were classified into this group and in only 5 was there no family history of the condition. There were 7 pedigrees with sibs affected and in 3 of these consanguinity was established beyond doubt. Both sexes were equally involved and the parents and children of affected individuals were all clinically normal. It is a very rare disorder and an extensive search has revealed only a small number of cases. All these features point to a single gene disorder with an autosomal recessive mode of inheritance.
The most striking clinical feature was the chronic oral candidiasis. Until recently, this infection was unresponsive to any form of treatment which included nystatin, amphotericin B, gentian violet, &c. In addition to the mouth lesions, the nails were usually affected, sometimes there was a mild intertrigo which probably represented a moniliid reaction and occasionally other sites showed abnormal lesions. At first I suggested that they might have an abnormality of their salivary IgA (Wells 1970) but this now seems unlikely. A range of abnormal responses to tests of cellmediated immunity were found in at least half the patients investigated, but were not uniformly present and may well be secondary to the chronic infection rather than the primary cause of the disease. None of these patients had any evidence of an endocrine disorder and extensive studies were carried out to exclude any abnormality of endocrine function.
Diffuse chronic mucocutaneous candidiasis: This is the name that we have given to the group of patients who were much more severely affected than those with familial chronic mucocutaneous candidiasis. In addition to the chronic oral and nail candidiasis, the pharynx, larynx, alimentary tract and other sites might be affected. With regard to the skin, the scalp, the face and upper chest were the areas most usually involved, sometimes giving rise to a candida granuloma. Occasionally they showed an abnormal susceptibility to other fungal infections such as Microsporum canis and more frequently an increased susceptibility to bacterial infection, for example of the chest and ears. In my own series 8 patients were classified in this group and none of them had a family history of the condition. There are several case reports of this condition in the literature. Candida-endocrinopathy syndrome: In addition to the chronic oral candidiasis these individuals may have candidal infection of the scalp, face, hands and nails. This infection may precede or post-date the hypoparathyroidism and hypo-adrenocorticism which were the endocrine abnormalities most generally found. The candida infection persists in spite of steroid replacement therapy. This syndrome may be inherited as an autosomal recessive trait. Late onset group: Finally there was a group of patients where the chronic oral candidiasis began after the age of 35 years and in many instances after the age of 50. None of the patients had a family history of the disorder and they were a heterogeneous group in whom the condition was probably acquired. In some no obvious cause was found, but in others the candidiasis was due to dentures. Occasionally the candidiasis was the manifestation of an internal malignancy and in particular of a malignant thymoma. The association of cutaneous candidiasis with a malignant thymoma is now well recognized and several patients have been described.
Conclusion
It will be seen from this brief review that patients with chronic oral candidiasis may need very extensive investigations before an accurate diagnosis can be made. Before the referral of 46 patients with chronic mucocutaneous candidiasis, a plan of investigation was made on the basis of the clinico-genetic observations and on previous reports of immunological defects associated with the disorder (e.g. Chilgren et al. 1969 , Valdimarsson et al. 1970 .
Cell-mediated immune responses were assessed by skin testing for delayed hypersensitivity and in vitro lymphocyte function tests. These were carried out to determine whether the type of immune defect usually encountered in the severely affected individuals with diffuse chronic mucocutaneous candidiasis (DCMC) was also present in patients from other clinico-genetic groups. One of these groups included patients with a genetically determined predisposition to the disease named familial chronic mucocutaneous candidiasis (FCMC), whose lesions remained largely confined to mouth and nails ).
Other etiological factors were considered, in particular those which might affect the integrity of the oral epithelium. This was suggested by two observations: (1) Maibach & Kligman (1962) showed that it was possible to produce cutaneous candidal infection under certain circumstances, but they were unable to induce a candidal lesion on a healthy oral mucous membrane. (2) Chronic oral candidiasis has been observed in several patients with a rare genetically determined disorder characterized by abnormal keratinization of oral epithelium, nails and skin. This condition is called pachyonychia congenita and is inherited as an autosomal dominant trait.
Of the biochemical factors known to influence the integrity of the oral epithelium, it was possible to measure serum iron, vitamin A and some vitamins of the B complex including pyridoxine.
Latent Iron Deficiency
Of the 20 patients who were diagnosed as having familial chronic mucocutaneous candidiasis and were fully investigated, 15 were found to have persistently low serum iron values with normal or raised iron binding capacity. Bone marrow samples were obtained from 12 of these patients and 9 showed a complete absence of stainable iron. However, their hemoglobin levels were not reduced, indicating that iron deficiency was latent in a significant proportion of cases. Previous records of 2 patients with FCMC showed evidence of latent iron deficiency at least ten years earlier.
Iron deficiency was also evident in patients from other clinico-genetic groups, in particular individuals with diffuse chronic mucocutaneous candidiasis, all of whom showed frank iron deficiency anemia .
Effect ofIron Therapy
Iron deficiency in the absence of aneemia is well documented (Fielding et al. 1965 ) but views differ on its clinical significance and the need to correct such a state.
Nearly all the patients studied in this survey had been treated with antifungal agents for several years without effect. There was also little clinical fluctuation in their condition. Preliminary observations on 3 patients treated with iron in addition to their usual local antifungal agents showed that there was significant clinical improvement in all 3 cases and the effect of iron was then studied by means of a small controlled trial.
All the patients included in the trial had evidence of iron deficiency without anemia and their lesions were usually confined to mouth and nails. There were 6 patients in each group and individuals were randomly allocated to treatment or placebo therapy. Because a preliminary investigation of iron uptake indicated the possibility of reduced iron absorption in some individuals with FCMC, patients included in the trial were given an intravenous infusion of Imferon, the dose ranging from 10 to 20 ml according to body weight. This was followed by oral iron therapy (ferrous fumarate 200 mg three times daily) for two months.
A clinical assessment was made at the beginning and end of the two-month period by three clinicians and photographs were taken of the lesions at the same time. Results: Of the 6 individuals on placebo therapy, 5 showed no appreciable change or were worse at the end of two months. One patient showed some spontaneous improvement. Five of these patients were subsequently treated in the same way as those in the other group and reassessed two months later. This increased the total number of treated patients to 11. Eight of them showed marked clinical improvement in their oral lesions at the end of two months. Two other patients improved when oral therapy was continued for a further two-month period and one showed no change after that time. The latter was the only patient to show a fall in the level of hemoglobin during the course of assessment.
Four other patients received oral iron only over a period of nine months, having had no evidence of impaired iron absorption. Another, who had thyrotoxicosis, was given parenteral iron but was not included in the trial. All showed significant clinical improvement; in the last case both oral and nail lesions cleared completely although the thyrotoxicosis was not treated until later. Regeneration of normal nail has been observed in several patients with FCMC when iron therapy was continued for at least six months. Only one patient, who had the candida-endocrinopathy syndrome, showed no response to parenteral iron. Cell-mediated responses: Five out of 11 patients, who were included in the trial, had abnormal tests of cell-mediated immunity. These abnormalities consisted either of depressed lymphocyte transformation to candida in the presence of an inhibitory serum factor, or lack of migration inhibition factor (MIF) to candida in the presence of normal lymphocyte transformation. Clinical improvement after iron therapy was observed whether defects in cell-mediated responses were present or not.
The tests of cell-mediated immunity were repeated in those patients with abnormal responses, after six months of iron therapy. This included individuals participating in the trial, as well as the 804 Proc. roy. Soc. Med. Volume 66 August 1973 20 relevant patients treated with oral iron only. Of 9 individuals with negative delayed skin tests to candida, 7 later developed a positive delayed hypersensitivity reaction and 2 also became able to produce a delayed response to dinitrochlorobenzene (DNCB).
Of 6 patients with abnormal in vitro lymphocyte function tests, 3 showed an improvement in response, particularly in respect of MIF production. Three showed no significant change, although clinical improvement.was observed. One other patient showed a change in her ability to produce MIF after one month on a contraceptive pill (Anovlar). She had not received iron therapy. Comment: It was difficult to draw any conclusions from these last observations, because wide fluctuations of in vitro lymphocyte function have been observed in some patients with FCMC over a period of time . These studies appear to support the observation that defects in cell-mediated immunity found in the more severely affected individuals with DCMC were usually constant, whereas those found in patients with FCMC might be subject to variation.
In addition, at least 40% of the individuals with FCMC had no demonstrable defect in lymphocyte function, suggesting that the various abnormal responses were more likely to be acquired than to constitute the primary genetically determined defect in this condition.
Iron Therapy in Two Patients with

Diffuse Chronic Mucocutaneous Candidiasis
Marked iron deficiency was present in 2 children with extensive cutaneous infection, one of whom developed granulomas of the scalp. Both had similar immunological defects, with negative delayed skin responses to candida and an inhibitory serum factor depressing lymphocyte transformation to candida. After an initial relapse, both children have remained almost free of cutaneous infection for more than fifteen months, using topical clotrimazole together with prolonged iron therapy, and both have shown marked improvement in their oral candidiasis despite the administration of antibiotics. It appears that the oral lesions were favourably influenced by continuous iron therapy but the effectiveness of topical clotrimazole precluded any assessment of its effect on their cutaneous lesions.
Discussion
Iron deficiency may be a secondary feature of FCMC and iron therapy may indirectly improve the quality of an oral epithelium which has an inherited defect. Such a defect might manifest itself in a local biochemical change predisposing towards the persistent development of the pathogenic hyphal form of candida.
The enzyme controlling yeast cell division is known to act on disulphide groups and its futnction may be inhibited by external changes in disulphide-sulfhydryl equilibria, leading to the development of the pathogenic hyphal form (Nickerson & Rij 1949 , Nickerson & Falcone 1956 .
Sulfhydryl groups are found in relatively large amounts in oral epithelium and changes in such equilibria may occur in iron-deficient individuals (Jacobs 1961 ). In addition a lack of cystine may be found in the nails of iron-deficient subject with koilonychia (Jalili & Al-Kassab 1959) . These changes may play a more important role in the development of oral and nail lesions than iron deficiency itself.
Conclusion
Chronic mucocutaneous candidiasis may occur in a variety of clinical situations. However, if the familial form (FCMC) could arise primarily as a result of a genetically determined defect localized to epithelial structures, further understanding of the relationships between iron and sulfhydryl metabolism may prove to be of some importance in this condition.
In addition, the need for further detailed investigations of cell-mediated une responses in iron-deficient subjects is suggested, which may prove to be of value in other clinical situations.
